浏览全部资源
扫码关注微信
中国药科大学国际医药商学院,南京 211198
Published:30 July 2024,
Received:08 December 2023,
Revised:24 June 2024,
扫 描 看 全 文
李梦颖,伍琳,王昕妍等.我国医保谈判药品落地问题的多重制度逻辑分析与政策建议 Δ[J].中国药房,2024,35(14):1683-1689.
LI Mengying,WU Lin,WANG Xinyan,et al.Multiple institutional logics analysis and policy suggestions on the use of national medical insurance negotiation drugs[J].ZHONGGUO YAOFANG,2024,35(14):1683-1689.
李梦颖,伍琳,王昕妍等.我国医保谈判药品落地问题的多重制度逻辑分析与政策建议 Δ[J].中国药房,2024,35(14):1683-1689. DOI: 10.6039/j.issn.1001-0408.2024.14.02.
LI Mengying,WU Lin,WANG Xinyan,et al.Multiple institutional logics analysis and policy suggestions on the use of national medical insurance negotiation drugs[J].ZHONGGUO YAOFANG,2024,35(14):1683-1689. DOI: 10.6039/j.issn.1001-0408.2024.14.02.
目的
2
厘清国家医保谈判药品(简称“国谈药”)落地难的制度逻辑,促进国谈药在医疗机构落地使用。
方法
2
基于医疗机构所处的复杂制度环境,以多重制度逻辑理论构建医疗机构行为选择的分析框架,阐明国谈药落地过程中多重逻辑的互动与冲突,揭示国谈药落地难的机制,并提出应对措施。结果与
结论
2
国谈药落地存在国家逻辑、市场逻辑、社会逻辑及专业逻辑四者间不同程度的矛盾与耦合。在多重逻辑博弈中,市场逻辑与专业逻辑倾向规避风险、国家逻辑的“压力型体制”失效、社会逻辑的作用不具有强制性,共同造成了当前医疗机构以完成绩效考核为目标而配备使用国谈药的行动力不足的局面。建议各级政府部门及医疗机构应以政策松绑解除国谈药落地的隐形限制、以激励约束形成医疗机构压力与动力、以绿色采购通道及时回应临床需求、以社会力量构建多方参与国谈药落地监督等,从而改善国谈药的落地效果。
OBJECTIVE
2
To clarify the institutional logics of the dilemma of the use of national medical insurance negotiation drugs(referred to as “national negotiation drugs”), and promote the implementation and use of these drugs in medical institutions.
METHODS
2
Based on the complex institutional environment in which medical institutions were situated, the theory of multiple institutional logics was used to construct an analytical framework for the behavioral choices of medical institutions, and reveal the mechanism of the difficulty in the use of national negotiation drugs by clarifying the interaction and conflict of multiple logics in this process, so as to put forward some measures.
RESULTS &CONCLUSIONS
2
There were contradictions and coupling among the state logic, market logic, social logic and professional logic in the use of national negotiation drugs. In the game of multiple logics, the market logic and professional logic tended to be risk-averse, the failed “pressure-type system” of state logic, and the social logic was weakened, which caused the lack of action in the use of national negotiation drugs with the goal of completing performance evaluations in the current medical institutions. Thus, it is suggested to unbundle the invisible policy restrictions on the use of national negotiation drugs, form the pressure and motivation of medical institutions by incentive and constraint mechanisms, respond to the clinical demand by establishing a green procurement channel, and construct the supervision mechanism on the use of national negotiation drugs by social force, etc., so as to enhance the effect of the national negotiation drugs.
医保谈判药品多重制度逻辑医疗机构制度环境行为选择
multiple institutional logicsmedical institutionsinstitutional environmentbehavioral choices
李伟,陈红斗,陆伟,等. 2016—2021年国家医保谈判药品可及性研究:基于全国大数据的实证分析[J]. 中国现代应用药学,2023,40(10):1405-1410.
LI W,CHEN H D,LU W,et al. Research on the accessibility of national medical insurance negotiation drugs from 2016 to 2021:an empirical analysis based on the national big data[J]. Chin J Mod Appl Pharm,2023,40(10):1405-1410.
陈玲玲,徐伟,尚波波,等. 国家谈判药品可获得性研究:基于苏州市公立医院采购数据的实证分析[J]. 卫生经济研究,2020,37(12):17-20.
CHEN L L,XU W,SHANG B B,et al. Research on the availability of national negotiated drugs:an empirical analysis based on the purchasing data of public hospitals in Suzhou[J]. Health Econ Res,2020,37(12):17-20.
李金龙,李明. 我国实现开发区高质量发展面临的问题与对策:基于多重制度逻辑的分析[J]. 广西社会科学,2020(3):50-58.
LI J L,LI M. Problems and countermeasures in realizing high-quality development zone in China:based on the analysis of multiple institutional logic[J]. Soc Sci Guangxi,2020(3):50-58.
FRIEDLAND R,ALFORD R. Bringing society back in:symbols,practices,and institutional contradictions[M]// POWELL W W,DIMAGGIO P J. The New Institutiona-lism in Organizational Analysis. Chicago:The University of Chicago Press,1991:232-263.
THORNTON P H,OCASIO W. Institutional logics and the historical contingency of power in organizations: executive succession in the higher education publishing industry,1958-1990[J]. Am J Sociol,1999,105(3):801-843.
THORNTON P H,OCASIO W,LOUNSBURY M. Precursors to the institutional logics perspective[M]//The In-stitutional Logics Perspective. Oxford:Oxford University Press,2012:20-49.
姚尚建,周健. 国家医保药品谈判的三个维度:药品、准入机制与市场的递进分析[J]. 中共福建省委党校(福建行政学院)学报,2021(4):71-77.
YAO S J,ZHOU J. Three dimensions of the national medical insurance drug negotiation:progressive analysis of drugs,access mechanism and market[J]. J Fujian Prov Comm Party Sch CPC (Fujian Acad Gov),2021(4):71-77.
THORNTON P H,OCASIO W. Institutional logics[M]// GREENWOOD R,OLIVER C, SUDDABY R,et al. The SAGE Handbook of Organizational Institutionalism. London:SAGE Publications Ltd,2008:99-129.
GREENWOOD R,DÍAZ A M,LI S X,et al. The multiplicity of institutional logics and the heterogeneity of organizational responses[J]. Organ Sci,2010,21(2):521-539.
叶托. 中国地方政府行为选择研究[D]. 杭州:浙江大学,2012.
YE T. Research on behavior choice of local government in China[D]. Hangzhou:Zhejiang University,2012.
雷小苗,李正风. 市场导向型基础研究:反向路径下的技术创新逻辑[J]. 科技管理研究,2020,40(21):1-6.
LEI X M,LI Z F. Market-oriented basic research:logic of technological innovation in the reverse path[J]. Sci Technol Manag Res,2020,40(21):1-6.
何谦然,邓大松,李玉娇. 中国公立医院改革历程的公共政策评估[J]. 社会保障研究,2014(1):3-13.
HE Q R,DENG D S,LI Y J. The evaluation on China’s reform of public hospitals based on public policy theory[J]. Soc Secur Stud,2014(1):3-13.
赵建国,廖藏宜. 我国基层公立医院管理体制改革实践模式分析[J]. 财经问题研究,2014(12):123-130.
ZHAO J G,LIAO Z Y. Analysis on the practice mode of management system reform in grass-roots public hospitals in China[J]. Res Financ Econ News,2014(12):123-130.
吕振波. 我国公立医院改革的制度困境与路径选择[J]. 锦州医科大学学报(社会科学版),2019,17(1):40-42.
LYU Z B. The system dilemma and path choice of public hospital reform in China[J]. J Jinzhou Med Univ Soc Sci Ed,2019,17(1):40-42.
李迁,武雨欣,胡毅,等. 多重制度逻辑视角下重大工程组织模式多样性分析[J]. 科学决策,2019(11):49-65.
LI Q,WU Y X,HU Y,et al. Diversity and evolution of megaproject organization modes in China:a perspective from multiple institutional logics[J]. Sci Decis Mak,2019(11):49-65.
王涛,陈金亮. 双元制度逻辑的共生演化与动态平衡:基于国有企业组织场域的解释[J]. 当代经济科学,2018,40(4):75-83,127.
WANG T,CHEN J L. The co-exiting evolution and dynamic balance of ambidextrous institution logics in the organization field of state-owned enterprises[J]. Mod Econ Sci,2018,40(4):75-83,127.
ROY M J,DONALDSON C,BAKER R,et al. Social enterprise:new pathways to health and well-being?[J]. J Public Health Policy,2013,34(1):55-68.
李振国.基于制度逻辑视角的科研院所治理研究[J].中国科技人才,2023(3):28-35.
LI Z G. Research on the governance of scientific research institutes from the perspective of institutional logics[J]. Sci Technol Talents China,2023(3):28-35.
郑胜华,徐玲晓. 移动医疗平台的制度逻辑动态均衡与政府规制[J]. 科技管理研究,2021,41(10):193-200.
ZHENG S H,XU L X. Dynamic balance of system logic and government regulation of mobile medical platform[J]. Sci Technol Manag Res,2021,41(10):193-200.
李宝庆,张善超,樊亚峤. 多重制度逻辑下高中学业水平考试改革的风险及其规避[J]. 教育发展研究,2016,36(6):1-8.
LI B Q,ZHANG S C,FAN Y Q. Risks and risks avoiding of the high school academic level test reform in multiple system[J]. Res Educ Dev,2016,36(6):1-8.
陈婧,夏彧. 学区制度化困境的多重逻辑分析[J]. 教育学报,2021,17(2):129-140.
CHEN J,XIA Y. Multiple logical analysis on the uncompleted institutionalization of the school district system[J]. J Educ Stud,2021,17(2):129-140.
江蒙喜,甘戈. 公立医院高质量发展的要素研究[J]. 卫生经济研究,2021,38(7):8-11.
JIANG M X,GAN G. Research on the elements of high-quality development of public hospitals[J]. Health Econ Res,2021,38(7):8-11.
刘丽英,陈晶. 公立医院公益性的回归[J]. 中国卫生经济,2015,34(3):47-49.
LIU L Y,CHEN J. On the fulfillment of the commonweal’s nature of public hospitals[J]. Chin Health Econ,2015,34(3):47-49.
周明华,谭红,肖葵,等. 三级公立医院绩效考核评价内涵及其思考[J]. 中国医院管理,2019,39(12):42-44.
ZHOU M H,TAN H,XIAO K,et al. Evaluation connotation of performance appraisal of tertiary public hospitals and hospital response[J]. Chin Hosp Manag,2019,39(12):42-44.
谢舜,陈宇. 城市养老服务中医养融合模式演变的多重逻辑[J]. 江汉论坛,2018(5):126-132.
XIE S,CHEN Y. Multiple logic on the modal evolution of medical treatment integrated with pension in cities[J]. Jianghan Tribune,2018(5):126-132.
谢金平,邵蓉. 国家医保谈判药品省级落地管理典型模式研究[J]. 中国卫生经济,2020,39(6):42-46.
XIE J P,SHAO R. Research on the typical model of provincial management concerning national medical insu-rance negotiation drugs[J]. Chin Health Econ,2020,39(6):42-46.
郑登滋,李玉水,陈纯,等. 福建省推进国家谈判药品政策落地情况调研及实证分析:基于集中采购与特药药房数据[J]. 中国医疗保险,2021(10):30-35.
ZHENG D Z,LI Y S,CHEN C,et al. Investigation and empirical analysis on the implementation of national negotiated drug policies in Fujian:based on centralized procurement and special drug pharmacy data[J]. China Health Insur,2021(10):30-35.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution